Moricizine
Risk Factor: BM
Class: CARDIOVASCULAR DRUGS
/ Cardiac Drugs
Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References
Questions and Answers
Fetal Risk Summary
Moricizine is an orally active agent used in the treatment of ventricular tachycardia. The drug is neither teratogenic nor fetotoxic in rats and rabbits at doses up to 6.7 and 4.7 times the maximum recommended human dose (1). No reports of the use of moricizine in human pregnancy have been located.
Breast Feeding Summary
The excretion of moricizine in human milk has been documented in one patient (data on file, Roberts Pharmaceutical Corporation, 1993), but no details on the amount in milk or its relationship to maternal levels are available. The clinical significance to the nursing infant is unknown.
References
-
Product information. Ethmozine. Roberts Pharmaceutical, 2000.
